RecruitingPhase 4NCT06354439

Use of Letrozole for Ectopic Pregnancy

Use of Letrozole in the Treatment of Early Ectopic Pregnancy


Sponsor

Hospital de Clinicas de Porto Alegre

Enrollment

130 participants

Start Date

Mar 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A randomized clinical trial using oral letrozole 10mg/day for 7 days, for treating early cases of ectopic pregnancy, compared to intramuscular methotrexate


Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Letrozole tablets and a drug called Methotrexate Sodium for people with ectopic pregnancy. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLetrozole tablets

10 mg of letrozole PO for 7 days

DRUGMethotrexate Sodium

100 mg of methotrexate IM, single dose


Locations(1)

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06354439


Related Trials